Loading…

EFFECTIVENESS OF A PROGRAM INTERVENTION WITH REDUCED-IRON MNPS ON MORBIDITY, IRON STATUS AND CHILD GROWTH IN YOUNG CHILDREN IN ETHIOPIA

Background and objectives: WHO recommends a daily micronutrient powder supplementation for all young children in populations with a prevalence of childhood anaemia. We assessed the effectiveness of an integrated program with low dose iron (6 mg) MNPs on morbidity, growth and iron status of children...

Full description

Saved in:
Bibliographic Details
Published in:Annals of nutrition and metabolism 2017-10, Vol.71 (Suppl. 2), p.837
Main Authors: Samuel, Aregash, Osendarp, Saskia, Adish, Abdul Aziz, Zarifopoulou, Aikaterina, Kebebe, Amha, Brouwer, Ingeborg
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and objectives: WHO recommends a daily micronutrient powder supplementation for all young children in populations with a prevalence of childhood anaemia. We assessed the effectiveness of an integrated program with low dose iron (6 mg) MNPs on morbidity, growth and iron status of children 6-23 months of age in Ethiopia. Methods: In a quasi-experimental design, 2356 infants 6-11 months of age, from program and matched-controlled clusters were followed longitudinally for 8 months. All children in program clusters received 15 sachets/month of lower iron dose (6 mg/serving) MNPs (15 nutrients formulation), in addition to a supply of locally produced complementary food. Iron status (Hemoglobin, serum Ferritin, sTfR) was assessed at base- and endline in a subsample. Morbidity from infectious diseases ((bloody) diarrhoea, upper and lower respiratory infections, fever and hospitalizations) were assessed every two weeks by recall. Anthropometry and information on infant feeding practices were collected every quarter Results: Changes in Hemoglobin concentrations during intervention differed significantly (p = 0.054) in intervention (+0.25; SD 1.50 g/dL) compared to non-intervention (-0.08; SD 1.13 g/ dL). An increase in height (+11.6; SD 2.9 cm and +10.7; SD 3.3 cm, p
ISSN:0250-6807
1421-9697
DOI:10.1159/000480486